These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regulation and Role of αE Integrin and Gut Homing Integrins in Migration and Retention of Intestinal Lymphocytes during Inflammatory Bowel Disease. Keir ME; Fuh F; Ichikawa R; Acres M; Hackney JA; Hulme G; Carey CD; Palmer J; Jones CJ; Long AK; Jiang J; Klabunde S; Mansfield JC; Looney CM; Faubion WA; Filby A; Kirby JA; McBride J; Lamb CA J Immunol; 2021 Nov; 207(9):2245-2254. PubMed ID: 34561227 [TBL] [Abstract][Full Text] [Related]
5. A mutation that blocks integrin α Zhang H; Zheng Y; Pan Y; Lin C; Wang S; Yan Z; Lu L; Ge G; Li J; Zeng YA; Chen J BMC Biol; 2020 Jun; 18(1):64. PubMed ID: 32522281 [TBL] [Abstract][Full Text] [Related]
6. Role of beta7 integrins in intestinal lymphocyte homing and retention. Gorfu G; Rivera-Nieves J; Ley K Curr Mol Med; 2009 Sep; 9(7):836-50. PubMed ID: 19860663 [TBL] [Abstract][Full Text] [Related]
8. [Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins]. Kim KO; Lee SH Korean J Gastroenterol; 2024 Aug; 84(2):43-50. PubMed ID: 39176460 [TBL] [Abstract][Full Text] [Related]
10. Anti-β7 integrin treatment impedes the recruitment on non-classical monocytes to the gut and delays macrophage-mediated intestinal wound healing. Sommer K; Heidbreder K; Kreiss L; Dedden M; Paap EM; Wiendl M; Becker E; Atreya R; Müller TM; Atreya I; Waldner M; Schürmann S; Friedrich O; Neurath MF; Zundler S Clin Transl Med; 2023 Apr; 13(4):e1233. PubMed ID: 37029786 [TBL] [Abstract][Full Text] [Related]
11. Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease. Tang MT; Keir ME; Erickson R; Stefanich EG; Fuh FK; Ramirez-Montagut T; McBride JM; Danilenko DM Aliment Pharmacol Ther; 2018 Jun; 47(11):1440-1452. PubMed ID: 29601644 [TBL] [Abstract][Full Text] [Related]
12. Dual targeting of lymphocyte homing and retention through α4β7 and αEβ7 inhibition in inflammatory bowel disease. Dai B; Hackney JA; Ichikawa R; Nguyen A; Elstrott J; Orozco LD; Sun KH; Modrusan Z; Gogineni A; Scherl A; Gubatan J; Habtezion A; Deswal M; Somsouk M; Faubion WA; Chai A; Sharafali Z; Hassanali A; Oh YS; Tole S; McBride J; Keir ME; Yi T Cell Rep Med; 2021 Aug; 2(8):100381. PubMed ID: 34467254 [TBL] [Abstract][Full Text] [Related]
13. The αE(CD103)β7 integrin interacts with oral and skin keratinocytes in an E-cadherin-independent manner*. Jenkinson SE; Whawell SA; Swales BM; Corps EM; Kilshaw PJ; Farthing PM Immunology; 2011 Feb; 132(2):188-96. PubMed ID: 20875079 [TBL] [Abstract][Full Text] [Related]
14. The Underappreciated Role of Secretory IgA in IBD. Bamias G; Kitsou K; Rivera-Nieves J Inflamm Bowel Dis; 2023 Aug; 29(8):1327-1341. PubMed ID: 36943800 [TBL] [Abstract][Full Text] [Related]
15. A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes. Stefanich EG; Danilenko DM; Wang H; O'Byrne S; Erickson R; Gelzleichter T; Hiraragi H; Chiu H; Ivelja S; Jeet S; Gadkari S; Hwang O; Fuh F; Looney C; Howell K; Albert V; Balazs M; Refino C; Fong S; Iyer S; Williams M Br J Pharmacol; 2011 Apr; 162(8):1855-70. PubMed ID: 21232034 [TBL] [Abstract][Full Text] [Related]
16. Past, Present and Future of Therapeutic Interventions Targeting Leukocyte Trafficking in Inflammatory Bowel Disease. Panés J; Salas A J Crohns Colitis; 2018 Aug; 12(suppl_2):S633-S640. PubMed ID: 30137311 [TBL] [Abstract][Full Text] [Related]
17. Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases. Saruta M; Papadakis KA Gastroenterol Clin North Am; 2014 Sep; 43(3):581-601. PubMed ID: 25110260 [TBL] [Abstract][Full Text] [Related]
18. Enrichment of T cells carrying beta7 integrins in inflamed synovial tissue from patients with early spondyloarthropathy, compared to rheumatoid arthritis. Elewaut D; De Keyser F; Van Den Bosch F; Lazarovits AI; De Vos M; Cuvelier C; Verbruggen G; Mielants H; Veys EM J Rheumatol; 1998 Oct; 25(10):1932-7. PubMed ID: 9779846 [TBL] [Abstract][Full Text] [Related]